Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
0.900
+0.031 (3.51%)
At close: Nov 20, 2024, 4:00 PM
0.920
+0.020 (2.22%)
After-hours: Nov 20, 2024, 7:15 PM EST
Hyperfine Revenue
Hyperfine had revenue of $3.64M in the quarter ending September 30, 2024, with 56.35% growth. This brings the company's revenue in the last twelve months to $13.26M, up 35.67% year-over-year. In the year 2023, Hyperfine had annual revenue of $11.03M with 61.90% growth.
Revenue (ttm)
$13.26M
Revenue Growth
+35.67%
P/S Ratio
4.90
Revenue / Employee
$101,183
Employees
131
Market Cap
65.36M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 11.03M | 4.22M | 61.90% |
Dec 31, 2022 | 6.81M | 5.32M | 355.48% |
Dec 31, 2021 | 1.50M | 1.20M | 408.84% |
Dec 31, 2020 | 294.00K | - | - |
Dec 31, 2019 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Xtant Medical Holdings | 113.86M |
Spero Therapeutics | 106.46M |
Atara Biotherapeutics | 100.44M |
Metagenomi | 55.08M |
Champions Oncology | 51.66M |
Celularity | 42.69M |
X4 Pharmaceuticals | 1.12M |
Monogram Technologies | 365.00K |
HYPR News
- 1 day ago - Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings - Business Wire
- 7 days ago - Hyperfine, Inc. to Participate in Upcoming Investor Conferences - Business Wire
- 8 days ago - Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Hyperfine, Inc. Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 13 days ago - Hyperfine Announces European Launch with CE Approval - Business Wire
- 21 days ago - Hyperfine Announces Alzheimer's Research with Promising Swoop® System Data and Advanced Image Quality - Business Wire
- 27 days ago - Hyperfine, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024 - Business Wire
- 7 weeks ago - Hyperfine Swoop® Portable MR Imaging® System Utilized in Multicenter SAFE MRI ECMO Study Published in the September 29th Issue of Circulation - Business Wire